The relationship of medical, demographic and psychosocial factors to direct and indirect health utility instruments in rheumatoid arthritis

Rheumatology

Volumn 45, Issue 8, 2006, Pages 975-981

  Witney, A G ^a,b   Treharne, G J ^a,b   Tavakoli, M ^c   Lyons, A C ^d   Vincent, K ^e   Scott, D L ^e   Kitas, G D ^a,b  

^a DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

^d MASSEY UNIVERSITY   (New Zealand)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Disability evaluation; Health utility; Rheumatoid arthritis; Standard gamble; Time trade off

Indexed keywords

ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; EDUCATION; EMPLOYMENT; FAMILY; FEMALE; FUNCTIONAL DISEASE; HEALTH CARE UTILIZATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; ARTHRITIS, RHEUMATOID; ATTITUDE TO HEALTH; COST-BENEFIT ANALYSIS; DEPRESSION; DISABILITY EVALUATION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 33747869954     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel027     Document Type: Article

References (50)

1. Symmons D, Turner G, Webb R et al. The prevalence of rheumatoid arthritis in the United Kingdom: New estimates for a new century. Rheumatology 2002;41:793-800.
2. Lindqvist E, Saxne T, Geborek P, Eberhardt K. Ten year outcome in a cohort of patients with early rheumatoid arthritis: Health status, disease process, and damage. Ann Rheum Dis 2002;61:1055-9.
3. Pincus T. The underestimated long term medical and economic consequences of rheumatoid arthritis. Drugs 1995;50:1-14.
4. Torrance GW. Toward a utility theory foundation for health status index models. Health Serv Res 1976;11:349-69.
5. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986;5:1-30.
6. Torrance GW. Utility approach to measuring health-related quality of life. J Chron Dis 1987;40:593-600.
7. Klose T. A utility-theoretic model for QALYs and willingness to pay. Health Econ 2003;12:17-31.
8. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997;36:551-9.
9. Marra CA, Rashidi AA, Guh D et al. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res 2005;14:1333-44.
10. Marra CA, Esdaile JM, Guh D et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005;60:1571-82.
11. Marra CA, Esdaile JM, Guh D et al. A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care 2004;42:1125-30.
12. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
13. Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted life-years by different preference-based measures. Med Care 2003;41:791-801.
14. De Wit GA, Busschbach JJV, De Charro FT. Sensitivity and perspective in the valuation of health status: Whose values count? Health Econ 2000;9:109-26.
15. Suarez-Almazor ME, Conner-Spady B. Rating of arthritis health states by patients, physicians and the general public: Implications for cost-utility analyses. J Rheumatol 2001;28:648-56.
16. Baker R, Robinson A. Responses to standard gambles: Are preferences 'well constructed'? Health Econ 2004;13:37-48.
17. Shiell A, Seymour J, Hawe P, Cameron S. Are preferences over health states complete? Health Econ 2000;9:47-55.
18. Breyer F, Fuchs VR. Risk attitudes in health: An exploratory study. Working Paper No. 875. Cambridge, MA: National Bureau of Economic Research, 1982 (available at: http://papers.nber.org/papers/w0875.pdf).
19. Nease RF, Tsai R, Hynes LM, Littenberg B. Automated utility assessment of global health. Qual Life Res 1996;5:175-82.
20. Tella MN, Feinglass J, Chang RW. Cost-effectiveness, cost-utility, and cost-benefit studies in rheumatology: A review of the literature, 2001-2002. Curr Opin Rheumatol 2003;15:127-31.
21. Hill J, Bird HA, Hopkins R, Lawton C, Wright V. The development and use of a patient knowledge questionnaire in rheumatoid arthritis. Br J Rheumatol 1991;30:45-9.
22. Treharne GJ, Lyons AC, Kitas GD. Medication adherence in rheumatoid arthritis: Effects of psychosocial factors. Psychol Health Med 2004;9:337-49.
23. Paulhus DL. Measurement and control of response bias. In: Robinson JP, Shaver PR, Wrightsman LS, ed. Measures of personality and social psychological attitudes, 2nd edn. New York: Academic Press, 1991:17-60.
24. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Dolan P, Gudex C, Kind P, Williams A. Valuing health states: A comparison of methods. J Health Econ 1996;15:209-31.
26. Kirwan JR, Reeback J. Stanford health assessment questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986;25:206-9.
27. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: A review of its history, issues, progress, and documentation. J Rheumatol 2003;30:167-78.
28. Escalante A, GalarzaDelgado D, Beardmore TD et al. Cross-cultural adaptation of a brief outcome questionnaire for Spanish-speaking arthritis patients. Arthritis Rheum 1996;39:93-100.
29. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: The health assessment questionnaire, disability and pain scales. J Rheumatol 1982;9:789-93.
30. Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: A comparison of six methods. Pain 1986;27:117-26.
31. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999;14:1-24.
32. Neame R, Hammond A. Beliefs about medications: A questionnaire survey of people with rheumatoid arthritis. Rheumatology 2005;44:762-7.
33. Funch DP, Marshall JR, Gebhardt GP. Assessment of a short scale to measure social support. Soc Sci Med 1986;23:337-44.
34. Treharne GJ, Lyons AC, Booth DA, Kitas GD. Perceived social support in rheumatoid arthritis patients: Extension of a general measure to cover support from healthcare professionals and its longitudinal impact on anxiety and depression. Rheumatology 2005;44(Suppl):i96.
35. Scheier MF, Carver CS. Optimism, coping and health: Assessment and implications of generalized outcome expectancies. Health Psychol 1985;4:219-47.
36. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
37. Bleichrodt H. A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Econ 2002;11:447-56.
38. Bleichrodt H, Johannesson M. Standard gamble, time trade-off and rating scale: Experimental results on the ranking properties of QALYs. J Health Econ 1997;16:155-75.
39. Morimoto T, Fukui T. Utilities measured by rating scale, time trade off and standard gamble: Review and reference for health care professional. J Epidemiol 2002;12:160-78.
40. Treharne GJ, Hale ED, Lyons AC et al. Cardiovascular disease and psychological morbidity among rheumatoid arthritis patients. Rheumatology 2005;44:241-6.
41. Treharne GJ, Lyons AC, Booth DA, Kitas GD. Predicting fatigue in rheumatoid arthritis: The impact of psychosocial resources 1 year earlier. Ann Rheum Dis 2005;64(Suppl):582.
42. Persson L-O, Berglund K, Sahlberg D. A structure of self-conceptions and illness conceptions in rheumatoid arthritis. J Psychosom Res 1996;49:535-49.
43. Newman S, Fitzpatrick R, Lamb R, Shipley M. The origins of depressed mood in rheumatoid arthritis. J Rheumatol 1989;16:740-4.
44. Guillemin F. The value of utility: Assumptions underlying preferences and quality adjusted life years. J Rheumatol 1999;26:1861-4.
45. Kitas GD, Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology 2003;42:607-13.
46. Bosch JL, Hunink MG. Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication. Qual Life Res 2000;9:591-601.
47. King JT, Styn MA, Tsevant J, Roberts MS. 'Perfect health' versus 'disease free': The impact of anchor point choice on the measurement and calculation of disease specific disutilities. Med Decis Making 2003;23:212-25.
48. McNamee P, Glendinning S, Shenfine J, Steen N, Griffin SM, Bond J. Chained time trade-off and standard gamble methods. Applications in oesophageal cancer. Eur J Health Econ 2004;5:81-6.
49. Kennedy ED, Detsky AS, Llewellyn-Thomas HA et al. Can the standard gamble be used to determine health utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn's disease. Med Decis Making 2000;20:70-8.
50. Oliver A. Testing the internal consistency of the lottery equivalents method using health outcomes. Health Econ 2005;14:149-59.